3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
68
Recurrence
7
Smoldering Multiple Myeloma
4
Neoplasms
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Plasmacytoma
1
Paraproteinemias
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
7
Biopsy
4
mogamulizumab
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Etoposide
3
ruxolitinib
2
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Busulfan
2
tofacitinib
1
tazemetostat
1
talimogene laherparepvec
1
sodium-iodide symporter
1
pembrolizumab
1
hypericin
1
cemiplimab
1
belinostat
1
X-Rays
1
Vorinostat
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
daratumumab
×
90 days
×
Clear all
No trials found.